• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病相关结直肠癌的手术切除范围:一项基于人群的研究。

Extent of Surgical Resection in Inflammatory Bowel Disease Associated Colorectal Cancer: a Population-Based Study.

机构信息

Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.

, Hamilton, Canada.

出版信息

J Gastrointest Surg. 2021 Oct;25(10):2610-2618. doi: 10.1007/s11605-021-04913-6. Epub 2021 Feb 8.

DOI:10.1007/s11605-021-04913-6
PMID:33559097
Abstract

BACKGROUND

The extent of surgical resection in inflammatory bowel disease (IBD) patients who develop colorectal cancer (CRC) is not prescribed by guidelines. We aim to evaluate, at a population level, the association of extent of surgical resection with survival outcomes.

METHODS

Using a validated Ontario registry of Crohn's disease (CD) and ulcerative colitis (UC) patients, we identified patients who underwent colorectal cancer resection between 2007 and 2015. Patient, tumor, and treatment factors, including type of surgical resection, were collected. Resections were grouped as segmental, total colectomy, and proctocolectomy. Multivariable cox proportional hazard regression was performed to identify factors associated with survival, including extent of surgical resection.

RESULTS

Between 2007 and 2015, 84,694 patients had resections for CRC in the province of Ontario, 599 had ulcerative colitis (UC), and 366 had Crohn's disease (CD). Segmental resection was the most common operation performed and was more common in CD patients compared to UC (68% vs. 45.6%, p < 0.001). Five-year survival was 63.7% (95% CI 59.5-67.7) in UC patients and 57.5% (95% CI 51.9-62.7) in CD patients (p = 0.033). Multivariable analysis showed worse survival in patients undergoing total colectomy, compared to segmental resection [HR 1.70 (95% CI 1.31-2.21), p < 0.001]. There was no significant difference in survival between patients undergoing segmental resection and proctocolectomy [HR 0.99 (95% CI 0.78-1.27)]. This pattern was similar within the subtypes of IBD.

CONCLUSION

In the setting of IBD-associated CRC, segmental resection and proctocolectomy are associated with similar survival outcomes in both UC and CD patients. Prospective study is essential to explore these findings.

摘要

背景

炎性肠病(IBD)患者发生结直肠癌(CRC)时的手术切除范围并未在指南中规定。我们旨在从人群水平评估手术切除范围与生存结果的相关性。

方法

我们使用经过验证的安大略省克罗恩病(CD)和溃疡性结肠炎(UC)患者登记处,确定了 2007 年至 2015 年间接受结直肠癌切除术的患者。收集了患者、肿瘤和治疗因素,包括手术切除类型。将切除术分为节段性、全结肠切除术和直肠结肠切除术。采用多变量 Cox 比例风险回归分析确定与生存相关的因素,包括手术切除范围。

结果

2007 年至 2015 年间,安大略省有 84694 例患者因 CRC 接受了切除术,其中 599 例为溃疡性结肠炎(UC),366 例为克罗恩病(CD)。节段性切除术是最常见的手术,且在 CD 患者中比 UC 患者更常见(68% vs. 45.6%,p<0.001)。UC 患者的 5 年生存率为 63.7%(95%CI 59.5-67.7),CD 患者为 57.5%(95%CI 51.9-62.7)(p=0.033)。多变量分析显示,与节段性切除术相比,全结肠切除术患者的生存状况更差[HR 1.70(95%CI 1.31-2.21),p<0.001]。节段性切除术与直肠结肠切除术患者的生存差异无统计学意义[HR 0.99(95%CI 0.78-1.27)]。在 IBD 相关 CRC 中,这种模式在 UC 和 CD 患者中均适用。需要前瞻性研究来探索这些发现。

相似文献

1
Extent of Surgical Resection in Inflammatory Bowel Disease Associated Colorectal Cancer: a Population-Based Study.炎症性肠病相关结直肠癌的手术切除范围:一项基于人群的研究。
J Gastrointest Surg. 2021 Oct;25(10):2610-2618. doi: 10.1007/s11605-021-04913-6. Epub 2021 Feb 8.
2
High-Grade Dysplasia in Inflammatory Bowel Disease: Indication for Colectomy.炎症性肠病中的高级别异型增生:结肠切除术的适应证。
Dis Colon Rectum. 2023 Feb 1;66(2):262-268. doi: 10.1097/DCR.0000000000002242. Epub 2022 Dec 27.
3
Implementation of a robotic surgical practice in inflammatory bowel disease.炎症性肠病机器人手术实践的实施。
J Robot Surg. 2024 Jan 28;18(1):57. doi: 10.1007/s11701-023-01750-4.
4
Long-term outcome of surgically treated Crohn's colitis: a prospective study.手术治疗克罗恩病性结肠炎的长期结局:一项前瞻性研究。
Dis Colon Rectum. 2005 May;48(5):963-9. doi: 10.1007/s10350-004-0906-3.
5
Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn's and ulcerative colitis based on three decades of experience.结直肠癌合并炎症性肠病:基于三十年经验的克罗恩病和溃疡性结肠炎的异同。
Ann Surg. 2010 Aug;252(2):330-5. doi: 10.1097/SLA.0b013e3181e61e69.
6
Do Thiopurines Reduce the Risk of Surgery in Elderly Onset Inflammatory Bowel Disease? A 20-Year National Population-Based Cohort Study.硫唑嘌呤能否降低老年起病炎症性肠病的手术风险?一项基于全国人群的20年队列研究。
Inflamm Bowel Dis. 2017 Apr;23(4):672-680. doi: 10.1097/MIB.0000000000001031.
7
Surgical outcome of inflammatory bowel disease - experience of a tertiary center.炎症性肠病的手术治疗结果——一家三级医疗中心的经验
Chirurgia (Bucur). 2013 Nov-Dec;108(6):812-5.
8
Appendectomy and Risk of Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: A Nationwide Population-based Cohort Study.阑尾切除术与炎症性肠病中晚期结直肠肿瘤风险:一项全国基于人群的队列研究。
Inflamm Bowel Dis. 2024 Jun 3;30(6):877-883. doi: 10.1093/ibd/izad141.
9
Rates of Intestinal Resection and Colectomy in Inflammatory Bowel Disease Patients After Initiation of Biologics: A Cohort Study.生物制剂治疗起始后炎症性肠病患者的肠道切除术和结肠切除术率:一项队列研究。
Clin Gastroenterol Hepatol. 2022 May;20(5):e974-e983. doi: 10.1016/j.cgh.2020.10.008. Epub 2020 Oct 14.
10
Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study.抗 TNF 治疗的引入并未使炎症性肠病的住院率和肠切除术率如预期般下降:一项基于人群的中断时间序列研究。
Gut. 2020 Feb;69(2):274-282. doi: 10.1136/gutjnl-2019-318440. Epub 2019 Jun 12.

引用本文的文献

1
Prognostic value of surgical treatment in elderly patients with ulcerative colitis-associated colorectal cancer: A subanalysis of a nationwide Japanese multicenter study.溃疡性结肠炎相关性结直肠癌老年患者手术治疗的预后价值:一项日本全国多中心研究的亚分析
Ann Gastroenterol Surg. 2024 Nov 12;9(3):486-495. doi: 10.1002/ags3.12885. eCollection 2025 May.
2
Colorectal Cancer and Inflammatory Bowel Disease.结直肠癌与炎症性肠病
Clin Colon Rectal Surg. 2024 Jun 24;38(3):198-202. doi: 10.1055/s-0044-1787891. eCollection 2025 May.
3
Oncological outcomes of patients with inflammatory bowel disease undergoing segmental colonic resection for colorectal cancer and dysplasia: systematic review.

本文引用的文献

1
Colorectal cancer surveillance in inflammatory bowel disease: Practice guidelines and recent developments.炎症性肠病中的结直肠癌监测:实践指南和最新进展。
World J Gastroenterol. 2019 Aug 14;25(30):4148-4157. doi: 10.3748/wjg.v25.i30.4148.
2
Age-Related Survival Differences in Patients With Inflammatory Bowel Disease-Associated Colorectal Cancer: A Population-Based Cohort Study.年龄相关性对炎症性肠病相关结直肠癌患者生存差异的影响:一项基于人群的队列研究。
Inflamm Bowel Dis. 2019 Nov 14;25(12):1957-1965. doi: 10.1093/ibd/izz088.
3
ACG Clinical Guideline: Ulcerative Colitis in Adults.
炎症性肠病患者因结直肠癌和发育异常接受节段性结肠切除术后的肿瘤学结局:系统评价
BJS Open. 2024 May 8;8(3). doi: 10.1093/bjsopen/zrae052.
4
Management of Colorectal Neoplasia in IBD Patients: Current Practice and Future Perspectives.炎症性肠病患者结直肠肿瘤的管理:现状与未来展望。
J Crohns Colitis. 2024 Oct 15;18(10):1726-1735. doi: 10.1093/ecco-jcc/jjae071.
5
Focal Cancer in Colitis.结肠炎中的局灶性癌症
Clin Colon Rectal Surg. 2023 Mar 15;37(1):22-29. doi: 10.1055/s-0043-1762560. eCollection 2024 Jan.
6
Rectal Cancer and Radiation in Colitis.直肠癌与结肠炎中的放疗
Clin Colon Rectal Surg. 2023 Feb 22;37(1):30-36. doi: 10.1055/s-0043-1762561. eCollection 2024 Jan.
7
Case Report: Malignant melanoma in a patient with Crohn's disease treated with ustekinumab.病例报告:使用乌司奴单抗治疗的克罗恩病患者发生恶性黑色素瘤。
F1000Res. 2023 Oct 4;11:424. doi: 10.12688/f1000research.110356.2. eCollection 2022.
8
Inflammatory Bowel Disease and Colorectal Cancer: Epidemiology, Etiology, Surveillance, and Management.炎症性肠病与结直肠癌:流行病学、病因学、监测与管理
Cancers (Basel). 2023 Aug 17;15(16):4154. doi: 10.3390/cancers15164154.
9
Clinical relevance of endoscopic peri-appendiceal red patch in ulcerative colitis patients.溃疡性结肠炎患者内镜下阑尾周围红色斑片的临床相关性
Therap Adv Gastroenterol. 2022 Jun 28;15:17562848221098849. doi: 10.1177/17562848221098849. eCollection 2022.
10
State-of-the-art surgery for Crohn's disease: Part II-colonic Crohn's disease and associated neoplasms.克罗恩病的最新手术治疗:第二部分-结肠克罗恩病和相关肿瘤。
Langenbecks Arch Surg. 2022 Nov;407(7):2595-2605. doi: 10.1007/s00423-022-02572-y. Epub 2022 Jun 22.
ACG 临床指南:成人溃疡性结肠炎。
Am J Gastroenterol. 2019 Mar;114(3):384-413. doi: 10.14309/ajg.0000000000000152.
4
Efficacy and Follow-up of Segmental or Subtotal Colectomy in Patients With Colitis-Associated Neoplasia.节段性或次全结肠切除术治疗结肠炎相关肿瘤的疗效及随访。
Clin Gastroenterol Hepatol. 2019 Jan;17(1):205-206. doi: 10.1016/j.cgh.2018.04.061. Epub 2018 May 8.
5
Emergency treatment of complicated colorectal cancer.复杂性结直肠癌的急诊治疗
Cancer Manag Res. 2018 Apr 20;10:827-838. doi: 10.2147/CMAR.S158335. eCollection 2018.
6
Segmental resection is a safe oncological alternative to total proctocolectomy in elderly patients with ulcerative colitis and malignancy.节段切除术是老年溃疡性结肠炎合并恶性肿瘤患者行全结肠直肠切除术的安全替代方案。
Colorectal Dis. 2017 Dec;19(12):1108-1116. doi: 10.1111/codi.13721.
7
Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers.炎症性肠病相关结直肠癌的全外显子组测序分析
Gastroenterology. 2016 Apr;150(4):931-43. doi: 10.1053/j.gastro.2015.12.036. Epub 2016 Jan 5.
8
European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies.欧洲循证共识:炎症性肠病与恶性肿瘤
J Crohns Colitis. 2015 Nov;9(11):945-65. doi: 10.1093/ecco-jcc/jjv141. Epub 2015 Aug 20.
9
Emergency presenting colon cancer is an independent predictor of adverse disease-free survival.急诊就诊的结肠癌是无病生存不良的独立预测因素。
Int Surg. 2015 Jan;100(1):77-86. doi: 10.9738/INTSURG-D-13-00281.1.
10
Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis.炎症性肠病中的结直肠癌:风险、发病机制、预防与诊断
World J Gastroenterol. 2014 Aug 7;20(29):9872-81. doi: 10.3748/wjg.v20.i29.9872.